The impact of dose-escalated RT on ADT in patients with intermediate risk prostate cancer

被引:0
|
作者
Onal, Cem [1 ,2 ]
Guler, Ozan Cem [1 ]
Erbay, Gurcan [3 ]
Elmali, Aysenur [2 ]
机构
[1] Baskent Univ, Dept Radiat Oncol, Fac Med, Adana, Turkiye
[2] Baskent Univ, Dept Radiat Oncol, Fac Med, Ankara, Turkiye
[3] Baskent Univ, Dept Radiol, Fac Med, Adana, Turkiye
关键词
ADT; Prostate cancer; Radiotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
126
引用
收藏
页码:S2293 / S2294
页数:2
相关论文
共 50 条
  • [11] Dose-escalated Radiation Therapy With and Without Short-course Androgen Deprivation for Intermediate-risk Prostate Cancer
    Schreiber, David
    Rineer, Justin
    Surapaneni, Aparna
    Navo, Elliot
    Agarwal, Manuj
    Nwokedi, Emmanuel
    Rotman, Marvin
    Schwartz, David
    ANTICANCER RESEARCH, 2014, 34 (08) : 4189 - 4193
  • [12] Prospective evaluation of probabilistic dose-escalated IMRT in prostate cancer
    Wegener, Daniel
    Berger, Bernhard
    Outtagarts, Zhoulika
    Zips, Daniel
    Paulsen, Frank
    Bleif, Martin
    Thorwarth, Daniela
    Alber, Markus
    Dohm, Oliver
    Mueller, Arndt-Christian
    RADIOLOGY AND ONCOLOGY, 2021, 55 (01) : 88 - 96
  • [13] Evaluation of the effectiveness of adding androgen deprivation to modern dose-escalated radiotherapy for men with favorable intermediate-risk prostate cancer
    Falchook, Aaron D.
    Basak, Ramsankar
    Mohiuddin, Jahan J.
    Chen, Ronald C.
    CANCER, 2016, 122 (15) : 2341 - 2349
  • [14] Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer
    Wang, Lora S.
    Murphy, Colin T.
    Ruth, Karen
    Zaorsky, Nicholas G.
    Smaldone, Marc C.
    Sobczak, Mark L.
    Kutikov, Alexander
    Viterbo, Rosalia
    Horwitz, Eric M.
    CANCER, 2015, 121 (17) : 3010 - 3017
  • [15] Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer
    Kalbasi, Anusha
    Li, Jiaqi
    Berman, Abigail T.
    Swisher-McClure, Samuel
    Smaldone, Marc
    Uzzo, Robert G.
    Small, Dylan S.
    Mitra, Nandita
    Bekelman, Justin E.
    JAMA ONCOLOGY, 2015, 1 (07) : 897 - 906
  • [16] LACK OF BENEFIT FOR THE ADDITION OF ANDROGEN DEPRIVATION THERAPY TO DOSE-ESCALATED RADIOTHERAPY IN THE TREATMENT OF INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER
    Krauss, Daniel
    Kestin, Larry
    Ye, Hong
    Brabbins, Donald
    Ghilezan, Michel
    Gustafson, Gary
    Vicini, Frank
    Martinez, Alvaro
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (04): : 1064 - 1071
  • [17] Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer The NRG Oncology RTOG 0126 Randomized Clinical Trial
    Michalski, Jeff M.
    Moughan, Jennifer
    Purdy, James
    Bosch, Walter
    Bruner, Deborah W.
    Bahary, Jean-Paul
    Lau, Harold
    Duclos, Marie
    Parliament, Matthew
    Morton, Gerard
    Hamstra, Daniel
    Seider, Michael
    Lock, Michael I.
    Patel, Malti
    Gay, Hiram
    Vigneault, Eric
    Winter, Kathryn
    Sandler, Howard
    JAMA ONCOLOGY, 2018, 4 (06)
  • [18] The impact of dose-escalated radiotherapy plus androgen deprivation for prostate cancer using 2 linked nomograms
    Stoyanova, Radka
    Pahlajani, Niraj H.
    Egleston, Brian L.
    Buyyounouski, Mark K.
    Chen, David Y. T.
    Horwitz, Eric M.
    Pollack, Alan
    CANCER, 2013, 119 (05) : 1080 - 1088
  • [19] Long-term outcome of biologically guided dose-escalated radiotherapy of localized prostate cancer
    Kuisma, Anna
    Wright, Pauliina
    Suilamo, Sami
    Seppala, Jan
    Koivisto, Mari
    Lindholm, Paula
    Minn, Heikki
    ACTA ONCOLOGICA, 2022, 61 (01) : 97 - 103
  • [20] The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer
    Murgic, Jure
    Stenmark, Matthew H.
    Halverson, Schuyler
    Blas, Kevin
    Feng, Felix Y.
    Hamstra, Daniel A.
    RADIATION ONCOLOGY, 2012, 7